Syringes - ANVISA Registration 80136719013
Access comprehensive regulatory information for Syringes in Brazil's medical device market through Pure Global AI's free database. This Risk Class II medical device is registered under ANVISA number 80136719013 and manufactured by MEDTRON AG. The registration is held by GUERBET IMAGEM DO BRASIL LTDA with validity until currently active (VIGENTE).
This page provides complete technical specifications for this device, regulatory compliance details, 5 similar products found using AI-powered semantic search, 5 companies making the same product including UNION MEDICAL SHENZHEN CO., LTD, SHENZHEN ANTMED CO.,LTD., and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.

Janaina dos Santos de Miranda
🇧🇷 Brazil Regulatory Expert
Need help with your Brazil registration?
Contact Pure Global Brazil TeamDevice Details
Registration Details
80136719013
25351118064202310
30153811000193
Company Information
Dates and Status
Mar 13, 2023
VIGENTE
09/18/2025 19:00:01
Syringes
SERINGA ELS PARA ANGIOGRAFIA GUERBET
MEDTRON AG
10061400027
Dec 26, 2006
Syringes
Seringa para Angiografia Guerbet
PEROUSE MEDICAL
80136719015
Jul 24, 2023
Disposable Syringes
SERINGA PARA ANGIOGRAFIA GUERBET
PEROUSE MEDICAL
10061400013
May 26, 2000
Syringes
Seringa para Angiografia
ANNTOM MEDICA LIMITED
82086770001
Feb 10, 2025
Syringes
Seringa Angiográfica
BIOTEQUE CORPORATION
80137019016
Jul 29, 2021
Seringas
Seringas Preenchidas OLIFLUSH
Not specified
80273450062
Sep 08, 2025
Seringas
Seringas Preenchidas OLIFLUSH
ZHEJIANG HOPE PHARMA CO., LTD.
80273450062
Sep 08, 2025
Seringas
SERINGA NANUM
NANUM COMPANY CO., LTD.
80886739002
Jul 28, 2025
Seringas
Kit de Seringa Dayset
SHENZHEN ANTMED CO.,LTD.
80102519342
Jun 30, 2025
Seringas
Kit Multi-paciente
SHENZHEN ANTMED CO.,LTD.
80102519337
Jun 09, 2025